Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Orchestra BioMed Holdings, Inc. | 8,306,063 | reported | 30 Apr 2025 | tx 3+2,858,412 |
| Avidity Biosciences, Inc. | 4,795,000 | reported | 04 Aug 2021 | tx 3+815,000−3,995,000 |
| Stoke Therapeutics, Inc. | 3,560,682 | reported | 04 Nov 2019 | tx 8+3,560,682−2,799,910 |
| Milestone Pharmaceuticals Inc. | 3,256,102 | reported | 22 Mar 2023 | tx 5+275,487−1,059,000 |
| Constellation Alpha Capital Corp. | 3,087,216 | reported | 07 Jan 2021 | tx 8+430,673.5−31,450 |
| TELA Bio, Inc. | 1,139,358 | reported | 17 Dec 2019 | tx 2+23,900−36,000 |
| Immunovant, Inc. | 902,498 | reported | 11 Dec 2019 | tx 23+902,498 |
| ALLURION TECHNOLOGIES, INC. | 767,848 | reported | 12 Nov 2025 | tx 11+5,205,115 |
| ROCKET PHARMACEUTICALS, INC. | 30,000 | reported | 18 Jun 2025 | tx 20+2,468,054−725,000 |
| PENWEST PHARMACEUTICALS CO | 0 | reported | 20 Sept 2010 | tx 2+20,000−20,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Nov 2025 | GRANT_AWARD | ALLURION TECHNOLOGIES, INC. | 96,896 | 1.67 USD | |
| 12 Nov 2025 | GRANT_AWARD | ALLURION TECHNOLOGIES, INC. | 767,848 | 1.67 USD | |
| 12 Nov 2025 | GRANT_AWARD | ALLURION TECHNOLOGIES, INC. | 991,544 | 1.67 USD | |
| 12 Nov 2025 | GRANT_AWARD | ALLURION TECHNOLOGIES, INC. | 767,848 | — | deriv |
| 12 Nov 2025 | GRANT_AWARD | ALLURION TECHNOLOGIES, INC. | 991,544 | — | deriv |
| 12 Nov 2025 | GRANT_AWARD | ALLURION TECHNOLOGIES, INC. | 96,896 | — | deriv |
| 18 Jun 2025 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 30,000 | 0.00 USD | |
| 18 Jun 2025 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 17,667 | 0.00 USD | |
| 30 Apr 2025 | PURCHASE | Orchestra BioMed Holdings, Inc. | 49,900 | 2.99 USD | first after silence |
| 16 Apr 2025 | CONVERSION | ALLURION TECHNOLOGIES, INC. | 822,722 | 3.35 USD | |
| 16 Apr 2025 | CONVERSION | ALLURION TECHNOLOGIES, INC. | 37,863 | 3.35 USD | |
| 16 Apr 2025 | CONVERSION | ALLURION TECHNOLOGIES, INC. | 631,954 | 3.35 USD | |
| 16 Apr 2025 | GRANT_AWARD | ALLURION TECHNOLOGIES, INC. | — | 5000000.00 USD | deriv |
| 16 Apr 2025 | CONVERSION | ALLURION TECHNOLOGIES, INC. | — | 5000000.00 USD | deriv |
| 12 Dec 2024 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 400,000 | 12.49 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 23,944 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 3,325 | 15.04 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 3,590 | 13.93 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | ROCKET PHARMACEUTICALS, INC. | 25,850 | 0.00 USD | deriv |
| 01 Dec 2022 | OTHER | Chardan Healthcare Acquisition 2 Corp. | 3,000,803 | — | |
| 01 Dec 2022 | OTHER | Chardan Healthcare Acquisition 2 Corp. | 350,000 | — | deriv |
| 22 Mar 2023 | OTHER | Milestone Pharmaceuticals Inc. | 1,059,000 | — | |
| 24 Jan 2023 | PURCHASE | Orchestra BioMed Holdings, Inc. | 1,808,512 | 10.00 USD | |
| 23 Dec 2022 | OTHER | ROCKET PHARMACEUTICALS, INC. | 1 | — | deriv |
| 22 Jul 2022 | PURCHASE | Orchestra BioMed Holdings, Inc. | 1,000,000 | 10.01 USD |
1 purchase reported after at least 12 months of silence — most recent on 30 Apr 2025.